BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6812000)

  • 1. Suppression of mitogen-induced lymphocyte transformation by plasma from patients with hepatosplenic Schistosomiasis mansoni: role of immune complexes.
    Kamal KA; Higashi GI
    Parasite Immunol; 1982 Jul; 4(4):283-98. PubMed ID: 6812000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression splenic T lymphocytes in human hepatosplenic Schistosomiasis mansoni.
    Ellner JJ; Olds GR; Kamel R; Osman GS; el-Kholy A; Mahmoud AA
    J Immunol; 1980 Jul; 125(1):308-12. PubMed ID: 6966656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent responses of peripheral blood and splenic mononuclear cells to antigenic and mitogenic stimulation in human hepatosplenic schistosomiasis.
    Reiner NE; Kamel R; Higashi GI; el-Naggar A; Aguib M; Ellner JJ; Mahmoud AA
    J Infect Dis; 1979 Aug; 140(2):162-8. PubMed ID: 314479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease.
    Colley DG; Garcia AA; Lambertucci JR; Parra JC; Katz N; Rocha RS; Gazzinelli G
    Am J Trop Med Hyg; 1986 Jul; 35(4):793-802. PubMed ID: 3089040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immune responses in human hepatosplenic schistosomiasis mansoni.
    Goodgame RW; Colley DG; Draper CC; Lewis FA; McLaren ML; Pelley RP
    Am J Trop Med Hyg; 1978 Nov; 27(6):1174-80. PubMed ID: 727322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of circulating immune complexes in the glomerular disease of experimental hepatosplenic schistosomiasis.
    Digeon M; Droz D; Noel LH; Riza J; Rieumailhol C; Bach JF; Santoro F; Capron A
    Clin Exp Immunol; 1979 Mar; 35(3):329-37. PubMed ID: 378479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of immune complexes in ascitic fluid of hepatosplenic schistosomiasis.
    Khalil HM; Makled MK; el Sebai MM; el Naggar MK
    J Egypt Soc Parasitol; 1987 Dec; 17(2):699-705. PubMed ID: 3121767
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune responses during human schistosomiasis mansoni. IX. T-lymphocyte subset analysis by monoclonal antibodies in hepatosplenic disease.
    Colley DG; Katz N; Rocha RS; Abrantes W; da Silva AL; Gazzinelli G
    Scand J Immunol; 1983 Apr; 17(4):297-302. PubMed ID: 6601292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum immunoglobulins in patients with schistosomiasis mansoni.
    GuimarĂ£es RX; PrĂ­coli TI; Novo NF; de Paiva ER
    Arq Gastroenterol; 1979; 16(1):3-7. PubMed ID: 475612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses during human schistosomiasis mansoni. VI. In vitro nonspecific suppression of phytohemagglutinin responsiveness induced by exposure to certain schistosomal preparations.
    Colley DG; Todd CW; Lewis FA; Goodgame RW
    J Immunol; 1979 Apr; 122(4):1447-53. PubMed ID: 312843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic human schistosomiasis mansoni-schistosomal antigen, immunoglobulins and complement C3 detection in the liver.
    De Brito T; Shimizu SH; Yamashiro E; Da Silva LC
    Liver; 1985 Apr; 5(2):64-70. PubMed ID: 3889530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatosplenic schistosomiasis mansoni: an immunologic disease.
    Warren KS
    Bull N Y Acad Med; 1975 Apr; 51(4):545-50. PubMed ID: 1091317
    [No Abstract]   [Full Text] [Related]  

  • 13. [Levels of anti-typhoid agglutinins in patients with hepatosplenic schistosomiasis].
    Yasuda MA; Ferri RG; Yasuda PH; Netto CF; da Silva GR; Ferreira JM
    Rev Saude Publica; 1982 Apr; 16(2):107-13. PubMed ID: 7146817
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation-induced apoptosis in peripheral blood mononuclear cells during hepatosplenic Schistosoma mansoni infections.
    Ghoneim HM; Demian SR; Heshmat MG; Ismail NS; El-Sayed LH
    Egypt J Immunol; 2008; 15(2):63-72. PubMed ID: 20306689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune profiles in hepatosplenic schistosomiasis mansoni after surgical treatments.
    Petroianu A; Antunes LJ
    J Int Med Res; 1998; 26(1):43-9. PubMed ID: 9513076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology of hepatosplenic schistosomiasis mansoni: a human perspective.
    Dunne DW; Pearce EJ
    Microbes Infect; 1999 Jun; 1(7):553-60. PubMed ID: 10603572
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of granulomatous hypersensitivity. IV. Immunoglobulin and antibody production by vigorous and immunomodulated liver granulomas of Schistosoma mansoni-infected mice.
    Boros DL; Amsden AF; Hood AT
    J Immunol; 1982 Mar; 128(3):1050-3. PubMed ID: 7035555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin-A and the pathogenesis of schistosomal glomerulopathy.
    Barsoum R; Nabil M; Saady G; Genin C; Saleh E; Francis M; el-Kalioubi A; Iskander I; el-Garem A
    Kidney Int; 1996 Sep; 50(3):920-8. PubMed ID: 8872967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Humoral immune response to typhoid vaccine in hepatosplenic schistosomiasis mansoni].
    Shikanai Yasuda MA; Yasuda PH; Ferri RG; de Castilho EA; Shiroma M
    Rev Inst Med Trop Sao Paulo; 1982; 24(4):198-204. PubMed ID: 7156703
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppressive effect of a chronic helminth infection, schistosomiasis mansoni, on the in vitro responses of spleen and lymph node cells to the T cell mitogens phytohemagglutinin and concanavalin A.
    Pelley RP; Ruffier JJ; Warren KS
    Infect Immun; 1976 Apr; 13(4):1176-83. PubMed ID: 1084329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.